At the end of the latest market close, Genocea Biosciences Inc. (GNCA) was valued at $2.45. In that particular session, Stock kicked-off at the price of $2.45 while reaching the peak value of $3.50 and lowest value recorded on the day was $2.41. The stock current value is $3.07.
Recently in News on January 4, 2021, Genocea to Present at the H.C. Wainwright Virtual BioConnect Conference. Genocea Biosciences, Inc. (NASDAQ: GNCA), a biopharmaceutical company developing next-generation neoantigen immunotherapies, today announced that Chip Clark, president and chief executive officer, will present a corporate overview at the H.C. Wainwright Virtual BioConnect Conference being held from January 11 – 14, 2021. A webcast of the on-demand presentation will be available on the investor section of the Genocea website at http://ir.genocea.com, beginning on Monday, January 11, 2021. You can read further details here
Gold bugs are shouting from the rooftops in excitement, but that doesn’t mean you rush out and just buy any gold stock…That’s why we laid out The 2021 Ultimate Gold Portfolio – to dissect the treasure from the trash.
Genocea Biosciences Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $3.50 on 01/13/21, with the lowest value was $2.34 for the same time period, recorded on 01/11/21.
Genocea Biosciences Inc. (GNCA) full year performance was 29.54%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Genocea Biosciences Inc. shares are logging -46.61% during the 52-week period from high price, and 179.09% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $1.10 and $5.75.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 3072835 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Genocea Biosciences Inc. (GNCA) recorded performance in the market was 26.86%, having the revenues showcasing 15.85% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 163.11M, as it employees total of 59 workers.
The Analysts eye on Genocea Biosciences Inc. (GNCA)
During the last month, 0 analysts gave the Genocea Biosciences Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 2.31, with a change in the price was noted +0.47. In a similar fashion, Genocea Biosciences Inc. posted a movement of +18.08% for the period of last 100 days, recording 413,133 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for GNCA is recording 0.68 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.
Technical rundown of Genocea Biosciences Inc. (GNCA)
Raw Stochastic average of Genocea Biosciences Inc. in the period of last 50 days is set at 74.71%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 69.06%. In the last 20 days, the company’s Stochastic %K was 56.33% and its Stochastic %D was recorded 53.41%.
Considering, the past performance of Genocea Biosciences Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 26.86%. Additionally, trading for the stock in the period of the last six months notably improved by 59.07%, alongside a boost of 29.54% for the period of the last 12 months. The shares increased approximately by 25.31% in the 7-day charts and went down by 40.83% in the period of the last 30 days. Common stock shares were driven by 15.85% during last recorded quarter.